Mitsubishi Chemical (MTLHY)
(Delayed Data from OTC)
$29.93 USD
0.00 (0.00%)
Updated Apr 12, 2024 12:28 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for Mitsubishi Chemical Holdings Corp falls in the month of March .
All items in Millions except EPS data.
3/31/24 | 3/31/23 | 3/31/22 | 3/31/21 | 3/31/20 | |
---|---|---|---|---|---|
Sales | NA | 34,296 | 35,395 | 30,621 | 32,941 |
Cost Of Goods | NA | 25,123 | 25,474 | 21,914 | 23,858 |
Gross Profit | NA | 9,172 | 9,921 | 8,707 | 9,083 |
Selling & Adminstrative & Depr. & Amort Expenses | 0 | 7,820 | 7,223 | 8,260 | 7,755 |
Income After Depreciation & Amortization | 0 | 1,352 | 2,698 | 447 | 1,327 |
Non-Operating Income | NA | 123 | 83 | 78 | 66 |
Interest Expense | NA | 232 | 198 | 215 | 271 |
Pretax Income | NA | 1,243 | 2,584 | 309 | 1,122 |
Income Taxes | NA | 243 | 721 | 96 | 481 |
Minority Interest | NA | 289 | 287 | 285 | 299 |
Investment Gains/Losses | NA | 0 | 0 | 0 | 0 |
Other Income/Charges | NA | 0 | 0 | 0 | 0 |
Income From Cont. Operations | NA | 1,000 | 1,864 | 214 | 641 |
Extras & Discontinued Operations | NA | 0 | 0 | 0 | 155 |
Net Income (GAAP) | NA | 711 | 1,577 | -71 | 498 |
Depreciation Footnote | 3/31/24 | 3/31/23 | 3/31/22 | 3/31/21 | 3/31/20 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 0 | 3,347 | 4,936 | 2,738 | 3,534 |
Depreciation & Amortization (Cash Flow) | NA | 1,995 | 2,238 | 2,292 | 2,206 |
Income After Depreciation & Amortization | 0 | 1,352 | 2,698 | 447 | 1,327 |
Earnings Per Share Data | 3/31/24 | 3/31/23 | 3/31/22 | 3/31/21 | 3/31/20 |
---|---|---|---|---|---|
Average Shares | NA | 284.35 | 308.03 | 284.10 | 284.02 |
Diluted EPS Before Non-Recurring Items | NA | 2.50 | 5.12 | -0.25 | 1.11 |
Diluted Net EPS (GAAP) | NA | 0.96 | 2.05 | -0.25 | 1.62 |
Fiscal Year end for Mitsubishi Chemical Holdings Corp falls in the month of March .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 7,416.98 | 7,534.59 | 7,747.07 | 9,288.91 |
Cost Of Goods | NA | NA | NA | 5,796.35 | NA |
Gross Profit | NA | NA | NA | 1,950.72 | NA |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | 1,462.50 | 0.00 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | 488.22 | 0.00 |
Non-Operating Income | NA | NA | NA | 96.89 | NA |
Interest Expense | NA | NA | NA | 82.80 | NA |
Pretax Income | NA | NA | NA | 502.31 | NA |
Income Taxes | NA | NA | NA | 94.79 | NA |
Minority Interest | NA | NA | NA | 97.00 | NA |
Investment Gains/Losses | NA | NA | NA | 0.00 | NA |
Other Income/Charges | NA | NA | NA | 0.00 | NA |
Income From Cont. Operations | NA | 248.21 | 170.78 | 407.52 | 597.60 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | 248.21 | 170.78 | 310.51 | 597.60 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 297.26 | 297.12 | 284.43 | 284.37 |
Diluted EPS Before Non-Recurring Items | NA | 0.83 | 0.57 | 1.09 | 2.10 |
Diluted Net EPS (GAAP) | NA | 0.83 | 0.57 | 0.42 | 2.10 |